TNXP - Tonix Pharmaceuticals Holding Corp
12.61
0.120 0.952%
Share volume: 276,382
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$12.49
0.12
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-13-2024 | 08-16-2024 | 11-12-2024 | 03-18-2025 | 05-12-2025 | 08-11-2025 | 11-10-2025 | 03-12-2026 | |
| Total revenue | 2.482 M | 2.208 M | 2.822 M | 2.582 M | 2.429 M | 1.998 M | 3.290 M | 5.390 M | |
| Cost of revenue | 1.660 M | 3.367 M | 1.555 M | 1.183 M | 943.000 K | 3.272 M | 1.367 M | 1.058 M | |
| Gross profit | 822.000 K | -1.159 M | 1.267 M | 1.399 M | 1.486 M | -1.274 M | 1.923 M | 4.332 M | |
| -241.00% | 209.32% | 10.42% | 6.22% | -185.73% | 250.94% | 125.27% | |||
| Operating expenses | 22.173 M | 17.200 M | 16.821 M | 23.879 M | 17.540 M | 27.022 M | 34.990 M | 52.618 M | |
| Selling general and admin | 9.310 M | 7.502 M | 7.707 M | 15.582 M | 10.104 M | 16.202 M | 25.701 M | 35.677 M | |
| Research and development | 12.863 M | 9.698 M | 9.114 M | 8.297 M | 7.436 M | 10.820 M | 9.289 M | 16.941 M | |
| Total expenses | 22.173 M | 76.157 M | 16.821 M | 23.879 M | 17.540 M | 27.022 M | 34.990 M | 52.618 M | |
| 243.47% | -77.91% | 41.96% | -26.55% | 54.06% | 29.49% | 50.38% | |||
| Operating income | -21.351 M | -77.316 M | -15.554 M | -22.480 M | -16.054 M | -28.296 M | -33.067 M | -48.286 M | |
| Ebit | -14.346 M | -78.171 M | -15.881 M | -24.232 M | -15.660 M | -30.251 M | -34.223 M | -48.864 M | |
| Pretax income | -14.346 M | -78.171 M | -15.881 M | -24.232 M | -17.752 M | -29.308 M | -32.992 M | -46.981 M | |
| 444.90% | -79.68% | 52.58% | -26.74% | 65.10% | 12.57% | 42.40% | |||
| Income tax | 0.000 | 0.000 | -1.668 M | 0.000 | -923.000 K | -1.036 M | -982.000 K | -71.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -14.939 M | -78.776 M | -14.213 M | -22.108 M | -16.829 M | -28.272 M | -32.010 M | -46.910 M | |
| -427.32% | 81.96% | -55.55% | 23.88% | -68.00% | -13.22% | -46.55% |